"BETonMACE is a Phase 3 cardiovascular event outcomes trial in approximately 2,425 high-risk cardiovascular patients with type II diabetes mellitus.......The BETonMACE trial is expected to be complete by the end of 2018 with the topline results expected shortly thereafter."

Well there were go. Fresh off the press. 2425 patients hasn't budged much from the late May ERA-EDTA poster that stated 2416 patients. And look at that......pretty bold statement on completion by end of 2018. SSRA? Maybe? Maybe not? Tough for me to see how they can not have 75% events at this point and still expect completion by year end. See this previous post too.

BearDownAZ